Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christopher Kenney, MD
Biotie Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
71 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Innsbruck, Austria
- Facility name not stated
Vienna, Austria
- Facility name not stated
Edmonton, Alberta, Canada
- Facility name not stated
Ottawa, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Brno, Czechia
- Facility name not stated
Choceň, Czechia
- Facility name not stated
Pardubice, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Rychnov nad Kněžnou, Czechia
- Facility name not stated
Beelitz-Heilstätten, Germany
- Facility name not stated
Berlin, Germany
- Facility name not stated
Dresden, Germany
- Facility name not stated
Haag in Oberbayern, Germany
- Facility name not stated
Marburg, Germany
- Facility name not stated
Ulm, Germany
- Facility name not stated
Arcugnano, Italy
- Facility name not stated
Cassino, Italy
- Facility name not stated
Chieti, Italy
- Facility name not stated
Grosseto, Italy
- Facility name not stated
Pavia, Italy
- Facility name not stated
Pisa, Italy
- Facility name not stated
Rome, Italy
- Facility name not stated
Salerno, Italy
- Facility name not stated
Venice, Italy
- Facility name not stated
Manresa, Barcelona, Spain
- Facility name not stated
Sant Cugat del Vallès, Barcelona, Spain
- Facility name not stated
Terrassa, Barcelona, Spain
- Facility name not stated
Donostia / San Sebastian, Guipuzcoa, Spain
- Facility name not stated
Barcelona, Spain
- Facility name not stated
Madrid, Spain
- Facility name not stated
Birmingham, Alabama, United States
- Facility name not stated
Sun City, Arizona, United States
- Facility name not stated
Loma Linda, California, United States
- Facility name not stated
Los Angeles, California, United States
- Facility name not stated
Oxnard, California, United States
- Facility name not stated
Reseda, California, United States
- Facility name not stated
Sacramento, California, United States
- Facility name not stated
Sunnyvale, California, United States
- Facility name not stated
Englewood, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2015
- Primary completion
- 12 Jan 2018
- Completion
- 12 Jan 2018
- Last update posted
- 3 Apr 2019
- Registered enrollment
- 449
- Registry id
- NCT02453386
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.